We are live on ! Find out more
Parallel Advisors

Parallel Advisors Portfolio holdings

AUM $6.56B Turnover 11.49%
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+6.71%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$3.11B
AUM Growth
+$140M
Cap. Flow
-$15.5M
Cap. Flow %
-0.5%
Top 10 Hldgs %
31.89%
Holding
3,618
New
197
Increased
1,211
Reduced
1,199
Closed
259
Avg Time Held Equity + Options
3.7 years
Top 10 Avg Time Held Equity + Options
2.1 years
Top 20 Avg Time Held Equity + Options
2.5 years
Avg Time Held Equity only
3.7 years
Top 10 Avg Time Held Equity only
2.1 years
Top 20 Avg Time Held Equity only
2.5 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 48.46%
2 Technology 15.44%
3 Healthcare 8.51%
4 Financials 6.64%
5 Consumer Discretionary 4.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ACVA icon
3351
ACV Auctions
ACVA
$1.78B
– –
-73
Closed -$942 –
RYM icon
3352
RYTHM Inc
RYM
$39.6M
– –
0
– -$24
2022 Q4
2 quarters
ALKT icon
3353
Alkami Technology
ALKT
$1.48B
– –
-43
Closed -$544 –
AMZD icon
3354
Direxion Daily AMZN Bear 1X ETF
AMZD
$15.4M
– –
-1,000
Closed -$27.2K –
ANGL icon
3355
VanEck Fallen Angel High Yield Bond ETF
ANGL
$3B
– –
-10
Closed -$280 –
ARVN icon
3356
Arvinas
ARVN
$446M
– –
-78
Closed -$2.13K –
ASND icon
3357
Ascendis Pharma A/S
ASND
$14.9B
– –
-74
Closed -$7.93K –
ASPN icon
3358
Aspen Aerogels
ASPN
$428M
– –
-78
Closed -$581 –
ATEN icon
3359
A10 Networks
ATEN
$1.96B
– –
-146
Closed -$2.26K –
ATRA icon
3360
Atara Biotherapeutics
ATRA
$96M
– –
-25
Closed -$1.82K –
AUB icon
3361
Atlantic Union Bankshares
AUB
$5.35B
– –
-751
Closed -$26.3K –
AVTX icon
3362
Avalo Therapeutics
AVTX
$635M
– –
0
– –
2020 Q1
13 quarters
BALY icon
3363
Bally's
BALY
$686M
– –
-4
Closed -$78 –
BBEU icon
3364
JPMorgan BetaBuilders Europe ETF
BBEU
$8.84B
– –
-1,202
Closed -$65.5K –
BBN icon
3365
BlackRock Taxable Municipal Bond Trust
BBN
$892M
– –
-1
Closed -$18 –
BCYC icon
3366
Bicycle Therapeutics
BCYC
$246M
– –
-5
Closed -$106 –
BGC icon
3367
BGC Group
BGC
$5.37B
– –
-453
Closed -$2.37K –
BHR.PRB icon
3368
Braemar Hotels & Resorts 5.50% Series B Preferred Stock
BHR.PRB
$45.9M
– –
-1,695
Closed -$27.2K –
CMRC icon
3369
Commerce.com Inc Series 1
CMRC
$272M
– –
-26
Closed -$232 –
BITO icon
3370
ProShares Bitcoin Strategy ETF
BITO
$1.65B
– –
-9,909
Closed -$174K –
BJRI icon
3371
BJ's Restaurants
BJRI
$1.27B
– –
-18
Closed -$525 –
BLBD icon
3372
Blue Bird Corp
BLBD
$1.93B
– –
-19
Closed -$388 –
BLND icon
3373
Blend Labs
BLND
$217M
– –
-1,398
Closed -$1.39K –
BNDD icon
3374
Quadratic Deflation ETF
BNDD
$13M
– –
-15
Closed -$1.9K –
BOC icon
3375
Boston Omaha
BOC
$382M
– –
-10
Closed -$237 –

Similar funds

Parallel Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, Parallel Advisors held 3,618 positions worth $3.11B, up 4.7% from $2.97B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Parallel Advisors's Q2 2023 filing shows 197 new, 1,211 increased, 1,199 reduced and 259 closed positions. Its largest new stake was JPMorgan Nasdaq Equity Premium Income ETF: 11,017 shares worth $533K. The largest sale was Invesco S&P 500 Equal Weight ETF, an estimated $39.5M.

By sector, the portfolio is most concentrated in Miscellaneous at 48% of assets, down from 50% a quarter earlier, followed by Technology and Healthcare.

  • Parallel Advisors's largest Q2 2023 buy was JPMorgan Nasdaq Equity Premium Income ETF: 11,017 shares worth $533K.
  • Parallel Advisors added most to iShares MSCI USA Quality Factor ETF in Q2 2023, an estimated $72.4M increase.
  • Parallel Advisors's biggest Q2 2023 reduction was Invesco S&P 500 Equal Weight ETF, cutting an estimated $39.5M.
  • Parallel Advisors fully exited Cvent Holding Corp. Common Stock in Q2 2023, selling an estimated $1.62M.
  • Parallel Advisors's ten largest holdings make up 32% of its $3.11B portfolio in Q2 2023.
  • Parallel Advisors opened 197 new positions and closed 259 in Q2 2023.
  • Parallel Advisors's portfolio value rose 4.7% quarter-over-quarter to $3.11B.

Based on Parallel Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.